Factors Contributing To Immune-Enhanced Disease In The Pathogenesis of RSV

RSV 发病机制中导致免疫增强性疾病的因素

基本信息

批准号：
7964834
负责人：
Barney Graham
金额：
$ 100.68万
依托单位：
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
依托单位国家：
美国
项目类别：
财政年份：
资助国家：
美国
起止时间：
至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/7964834
关键词：
Adjuvant Adult Animal Model CD4 Positive T Lymphocytes CD8B1 gene Cell Maturation Cell physiology Child Childhood Asthma Cytotoxic T-Lymphocytes Dendritic Cells Development Disease Exposure to Glycoproteins Hospitalization Immune Immune response Immunity Immunization Infection Integration Host Factors Interleukin-4 Neonatal Pathogenesis Recording of previous events Respiratory Syncytial Virus Infections Respiratory Syncytial Virus Vaccines Respiratory Tract Infections Respiratory syncytial virus Respiratory syncytial virus RSV G glycoprotein Respiratory syncytial virus RSV proteins Structure T-Lymphocyte Vaccinated Vaccine Therapy Vaccines Viral Virus Virus Activation Virus Diseases aluminum sulfate design eosinophil experience glycoprotein G human subject killings mouse model research study response vaccine development vector virus pathogenesis

项目摘要

Respiratory syncytial virus (RSV) infection is the primary cause of respiratory infection in young children, causing >120,000 hospitalizations in the US annually. RSV vaccine development has been hampered by the history of a failed vaccine trial in the early 1960s in which vaccinated children were not protected against subsequent natural infection but rather experienced more severe disease. Subsequent experiments in animal models and human subjects suggest the occurrence of severe RSV disease correlates with the induction of virus-specific Th2 CD4+ T cells and eosinophil recruitment and degranulation. The putative attachment G glycoprotein of RSV and killed virus vaccines containing adjuvants such as alum are particularly effective in inducing such disease-enhancing immune responses. The purposes of these studies are 1) to define the precise components of RSV immunity that predispose for severe RSV disease upon subsequent exposure to the virus, 2) to determine how the structure of RSV contributes to disease, and 3) with this better understanding of RSV pathogenesis, to rationally design RSV vaccines that protect against infection without enhancing disease.

呼吸道合胞病毒（RSV）感染是幼儿呼吸道感染的主要原因，每年在美国导致> 120,000次住院。 1960年代初期的一项疫苗试验失败的疫苗试验病史阻碍了RSV疫苗的开发，其中未能保护接种疫苗的儿童免受随后的自然感染的保护，而是经历了更严重的疾病。随后在动物模型和人类受试者中进行的实验表明，严重的RSV疾病的发生与病毒特异性TH2 CD4+ T细胞的诱导以及嗜酸性粒细胞募集和脱粒相关。 RSV的假定附着G糖蛋白和杀死含有明矾等佐剂的病毒疫苗在诱导这种增强疾病的免疫反应方面特别有效。这些研究的目的是1）定义RSV免疫的确切组成部分，后来暴露于病毒后，患有严重的RSV疾病，2）确定RSV的结构如何对疾病有效，3）对RSV病原体的更好理解，对RSV病原体的理解，从理性地设计RSV疫苗，以防止疾病，而无需增强感染疾病。